InvestorsHub Logo
Followers 2134
Posts 93139
Boards Moderated 0
Alias Born 12/17/2011

Re: None

Thursday, 09/10/2020 9:15:04 AM

Thursday, September 10, 2020 9:15:04 AM

Post# of 3516
DFFN...92...in the P/M...CHARLOTTESVILLE, Va., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”) today announced dosing of the first two patients in the Company’s open-label Phase 1b lead-in trial of its novel, oxygen-enhancing therapeutic, trans sodium crocetinate (“TSC”), in 24 hospitalized COVID-19 patients. In addition to evaluating the safety and tolerability of TSC, this trial will collect preliminary data on TSC’s effects on arterial blood oxygenation. The Company believes these pharmacodynamic data will provide proof of concept for TSC in hypoxemic patients, and these data will be used to guide design of the planned follow-on efficacy study...

https://www.otcmarkets.com/stock/DFFN/news/story?e&id=1689210

Its is not about how much profit you make on a trade but how many profitable trades you are able to make...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DFFN News